TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Receptor tyrosine kinases (RTKs) are crucial in cancer development.
• Aberrant activation of wild-type (WT) RTKs contributes to cancer progression.
• Mechanisms of RTK involvement in prostate cancer metastasis are not fully understood.

Purpose of the Study:

• To investigate the role of non-proteolytic ubiquitination in RTK-mediated prostate cancer metastasis.
• To identify specific E3 ubiquitin ligases and RTKs involved in this process.
• To elucidate the molecular mechanisms by which RTK activity is regulated in prostate cancer.

Main Methods:

• Investigated the function of TRAF4 (an E3 ubiquitin ligase) in prostate cancer metastasis.
• Identified TrkA (a neurotrophin RTK) as a substrate for TRAF4-mediated ubiquitination.
• Analyzed the impact of TRAF4 on TrkA kinase activity, autophosphorylation, and downstream signaling pathways (e.g., p38 MAPK).
• Examined ubiquitination site mutations and their effect on TrkA function.
• Correlated TRAF4 levels with gene expression in patient samples.

Main Results:

• TRAF4 is highly expressed in metastatic prostate cancer and promotes RTK-mediated metastasis.
• TRAF4 targets TrkA for K27- and K29-linked ubiquitination, increasing its kinase activity.
• Ubiquitination of TrkA by TRAF4 enhances cancer cell invasion and NGF-stimulated signaling.
• Inhibition of TrkA activity or TRAF4 knockdown suppresses invasion and downstream signaling.
• Elevated TRAF4 levels correlate with increased invasion-associated gene expression in prostate cancer patients.

Conclusions:

• Non-proteolytic ubiquitination of RTKs is a key mechanism driving prostate cancer metastasis.
• TRAF4-mediated ubiquitination of TrkA enhances its kinase activity and promotes invasion.
• This posttranslational modification pathway represents a potential therapeutic target for metastatic prostate cancer.